YBX1 and cancer: Furthermore, our results provide new insights into the design of a novel oncolytic adenovirus driven by the MDR-1 promoter, which is regulated by YB-1 that is highly expressed in various cancers, in particular more advanced and chemotherapy-resistant tumors.